SEE FULL COMPANY PROFILES WITH A FREE TRIAL
EMIS is the definitive emerging markets news, research, company, and financial data resource. EMIS - ISI Emerging MarketsLEARN MORE
Search for another company:
ALL
Romania
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).

Infomed Fluids

Main Activities: Pharmaceutical and Medicine Manufacturing

facebook Please check the full coverage of information what EMIS can offer you. SEE SAMPLE

Company Information

Full name
Infomed Fluids SRL

Headquarters
50, THEODOR PALLADY St.; BUCURESTI; Bucharest; 032266
Status: Non-Listed
Legal Form: Limited Liability Company
Operational Status: Operational
CUI: 16674718
Incorporation Date: January 1, 2004
Total Employees: 391

Tel: 00 40.21.345.02.22

Company Description

Infomed Fluids is a progressive pharmaceutical company specializing in the development and manufacture of small and large volume parenteral infusions in bags and glass bottles. Infomed Fluids is a subsidiary of ACS DOBFAR INFO (Switzerland), the well-known branch of ACS DOBFAR HOLDING, which has played an important part in the world market of antibiotics and cefalosporine production for over 30 years.

Company Analysis

According to the Individual - Non-Audited financial statement for the Year of 2011, total net operating revenues increased with 27.38%, from RON 96,928,687 to RON 123,466,222 . Operating result decreased from RON 22,147,783 to RON 19,633,318 which means -11.35% change. The results of the period decreased -17.59% reaching RON 14,416,592 at the end of the period against RON 17,493,038 last year. Return on equity (Net income/Total equity) went from 35.74% to 21.12%, the Return On Asset (Net income / Total Asset) went from 14.87% to 9.98% and the Net Profit Margin (Net Income/Net Sales) went from 18.05% to 11.68% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 111.65% compared to 140.37% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 1.26 to 1.66 when compared to the previous year.

Key Executives

Rodica Diaconu Quality Manager
More

Companies with Similar Main Activities

ISI Emerging Markets

FULL COMPANY PROFILE

Please check the full coverage of information what EMIS can offer you.
SEE SAMPLE
SELECT CURRENCY
Balance Sheet

Total Assets

144,478,924

131,608,241

Current Assets

XX,XXX,XXX

XX,XXX,XXX

Total Liabilities

XX,XXX,XXX

XX,XXX,XXX

Shareholders Equity

XX,XXX,XXX

XX,XXX,XXX

Current Liabilities

XX,XXX,XXX

XX,XXX,XXX

* All the accounts are in RON.
Income Statement

Total Operating Revenue

XXX,XXX,XXX

XX,XXX,XXX

Operational Profit (Loss)

XX,XXX,XXX

XX,XXX,XXX

Net Profit (Loss)

XX,XXX,XXX

X,XXX,XXX

* All the accounts are in RON.
Ratios
Profitability Ratios

Return on Assets (ROA)

X.XX%

X.XX%

Annualised Return on Assets (ROA)

X.XX%

XX.XX%

Return on Equity (ROE)

XX.XX%

XX.XX%

Annualised Return on Equity (ROE)

XX.XX%

XX.XX%

Return on Sales (ROS)

XX.XX%

XX.XX%

Return on Capital

XX.XX%

XX.XX%

Gross Profit Margin

XX.XX%

XX.XX%

Operating Profit Margin

XX.XX%

XX.XX%

Efficiency Ratios

Accounts Receivable Turnover

X.XXx

X.XXx

Inventory Turnover

X.XXx

X.XXx

Current asset turnover

X.XXx

X.XXx

Fixed-asset turnover

X.XXx

X.XXx

Asset Turnover

X.XXx

X.XXx

Valuation figures and ratios

Earning Before Interests and Taxes (EBIT)

XX,XXX,XXX

XX,XXX,XXX

EBITDA

XX,XXX,XXX

XX,XXX,XXX

Bookvalue (BV)

XX,XXX,XXX

XX,XXX,XXX

Net Cash

-XX,XXX,XXX

-XX,XXX,XXX

Liquidity Ratios

Current Ratio

XXX.XX%

XXX.XX%

Quick ratio

XXX.XX%

XXX.XX%

Doom's day ratio

X.XX%

X.XX%

Leverage Ratios

Leverage ratio

XXX.XX%

XXX.XX%

Interest Coverage Ratio

X.XX%

X.XX%

Debt to equity

XXX.XX%

XXX.XX%

Debt to total assets

XX.XX%

XX.XX%

Long Term Debt to Capital

XX.XX%

XX.XX%